KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $584.3 million.

  • Exact Sciences' Total Current Liabilities fell 1926.34% to $584.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $584.3 million, marking a year-over-year decrease of 1926.34%. This contributed to the annual value of $732.2 million for FY2024, which is 4225.48% up from last year.
  • Exact Sciences' Total Current Liabilities amounted to $584.3 million in Q3 2025, which was down 1926.34% from $521.9 million recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' Total Current Liabilities peaked at $732.2 million during Q4 2024, and registered a low of $367.4 million during Q1 2023.
  • Over the past 5 years, Exact Sciences' median Total Current Liabilities value was $517.1 million (recorded in 2021), while the average stood at $555.7 million.
  • Per our database at Business Quant, Exact Sciences' Total Current Liabilities skyrocketed by 20399.33% in 2021 and then plummeted by 4034.67% in 2022.
  • Quarter analysis of 5 years shows Exact Sciences' Total Current Liabilities stood at $517.1 million in 2021, then decreased by 20.18% to $412.7 million in 2022, then increased by 24.7% to $514.7 million in 2023, then skyrocketed by 42.25% to $732.2 million in 2024, then fell by 20.2% to $584.3 million in 2025.
  • Its last three reported values are $584.3 million in Q3 2025, $521.9 million for Q2 2025, and $502.5 million during Q1 2025.